Nazli Azimi

I am a biotech executive and co-founder of 3 biotech companies in the therapeutic space. I enjoy working in the translational space where I can help convert cutting-edge discoveries to actual therapeutics that can impact people’s lives. In my newest venture, Therna Therapeutics, I am teamed up with top investigators from the UCSF and ARC Institute who have pioneered the work in the intersection of RNA biology and AI and built the largest foundation model for generative RNA design. Leveraging this expertise, we design programable RNA medicines with characteristics that have not been possible before, pushing the boundaries of what nature has been able to do.

Therna Therapeutics
Wednesday
May 07
Next-Gen Medicine: AI-Powered Advances Reshaping Human Therapeutics
3:30 PM

-

4:15 PM

Dive into the cutting-edge today, not just the promises of tomorrow. This dynamic breakout session features biotech visionaries actively leveraging machine learning and AI to transform the engineering of human therapeutics. Hear firsthand from industry pioneers pushing the boundaries—from accelerating drug target discovery to streamlining clinical development pipelines. Learn how advanced analytics and big data are already enhancing personalized medicine, boosting clinical success rates, and rapidly reshaping the future landscape of healthcare. Don't miss this inside look at the real-world innovations redefining what's possible in therapeutic discovery and precision medicine.

Conference Pass

2,495

USD

Keynotes & Firesides

Workshops & Breakouts

1:1 Partnering App

Meals & Receptions

Session Recordings

Until Friday April 18th

Full Rate:

$3,495

Other Speakers

Copyright SynBioBeta 2025